Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, commonly causing nausea, diarrhoea, vomiting, and abdominal discomfort during treatment
Online care can be a good starting point for straightforward casesyour clinician reviews symptoms, history, allergies, and current medications before deciding whether treatment is appropriate
Order today and benefit from our complete, all-inclusive service
Repeating injections in the same spot can cause constant irritation in the fatty layer
plantarum strains broadly shows promise for gut health
Managing expectations during month six By six months, clinical trial participants lost an average of 10 to 15 percent of their starting body weight, though individual results varied widely from five percent to over 20 percent depending on starting weight, dose achieved, and adherence to lifestyle modifications